Oral complications of cancer and cancer therapy: from cancer treatment to survivorship

JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

The CyberKnife® robotic radiosurgery system in 2010

W Kilby, JR Dooley, G Kuduvalli… - … in cancer research …, 2010 - journals.sagepub.com
This review provides a complete technical description of the CyberKnife® VSI™ System, the
latest addition to the CyberKnife product family, which was released in September 2009 …

Delivering affordable cancer care in high-income countries

R Sullivan, J Peppercorn, K Sikora, J Zalcberg… - The lancet …, 2011 - thelancet.com
The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …

[HTML][HTML] Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary

TD Solberg, JM Balter, SH Benedict, BA Fraass… - Practical radiation …, 2012 - Elsevier
This executive summary briefly describes the overall goals and content of the report on
safety consideration for stereotactic radiosurgery (SRS) and stereotactic body radiation …

Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy

J Grimm, T LaCouture, R Croce, I Yeo… - Journal of applied …, 2011 - Wiley Online Library
Almost 20 years ago, Emami et al. presented a comprehensive set of dose tolerance limits
for normal tissue organs to therapeutic radiation, which has proven essential to the field of …

A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell …

JA Vargo, RL Ferris, J Ohr, DA Clump, KS Davis… - International Journal of …, 2015 - Elsevier
Purpose Salvage options for unresectable locally recurrent, previously irradiated squamous
cell carcinoma of the head and neck (rSCCHN) are limited. Although the addition of …

A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer

JA Vargo, MC Ward, JJ Caudell, N Riaz… - International Journal of …, 2018 - Elsevier
Purpose Two modern methods of reirradiation, intensity modulated radiation therapy (IMRT)
and stereotactic body radiation therapy (SBRT), are established for patients with recurrent or …

Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate

P Strojan, J Corry, A Eisbruch, JB Vermorken… - Head & …, 2015 - Wiley Online Library
Background Local and/or regional recurrence and metachronous primary tumor arising in a
previously irradiated area are rather frequent events in patients with head and neck …

Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses

V Takiar, AS Garden, D Ma, WH Morrison… - International Journal of …, 2016 - Elsevier
Purpose To review our 15-year institutional experience using intensity modulated radiation
therapy (IMRT) to reirradiate patients with head and neck squamous cell carcinomas …

Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas

JCM Rwigema, SD Parikh, DE Heron… - American journal of …, 2011 - journals.lww.com
Objectives: The aim of the study was to assess the feasibility and safety of stereotactic body
radiotherapy (SBRT) in patients with advanced pancreatic adenocarcinoma. Methods: We …